About
Kyron Bio is a biotechnology company in Paris, France that engineers glycans to expand what protein therapeutics can do. It works on therapeutic design with a focus on controlling N-glycans on therapeutic proteins and developing better treatments.
Services
Glycan engineering for therapeutic proteins
Uses computational protein design and glycoengineered cell lines to control N-glycan structure and place new N-glycans at defined positions on therapeutic proteins.
Glycan library development
Produces a library of homogeneous N-glycan structures for use in drug design, including bi-antennary, tri-antennary and tetra-antennary forms.
Cell line engineering
Develops glycoengineered cell lines to enable precise control of N-glycan structures.
Glycan engineering platform
Combines computational protein design with glycoengineered cell lines to control N-glycan structure and introduce new N-glycans at defined positions on therapeutic proteins.
Therapeutic protein design with programmed N-glycans
Designs N-glycans as a feature of therapeutic proteins rather than accepting glycosylation as an uncontrolled outcome.
Cell-line engineering for glycosylation control
Uses engineered cell lines to precisely control N-glycan structure on produced biologics.
Capabilities
- Assays and studies
- Antibodies
- Therapeutic areas
- Therapeutics
Modalities and species
- Modalities
- Antibody
- Species and models
- CHO · CHO cell lines
Industries served
- Biotech
Locations
- Based in
- Paris, France
- Sites
- Paris, France
Similar labs
Work here? Claim this listing